TrialJournal of acquired immune deficiency syndromes (1999)2016

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.

Barbara A Friedland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.